58 reports

  • Global Cervical Cancer Diagnostics
  • B: Cervical Cancer Flowchart

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies),...

  • Cervical Cancer
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • Cervical Cancer Key Statistics
  • 8.2 Canada Cervical Cancer Mortality

Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital Human Papilloma Virus (HPV) infection. As cervical cancer is a disease with long latent period, early detection and treatment of precancerous lesions is known to be highly effective...

  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Medical Device
  • Sexually Transmitted Disease
  • Forecast
  • Cervical cancer: An overview
  • Global cervical cancer diagnostic testing market ($ billions)

About Cervical Cancer Diagnostic Testing The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages...

  • Cervical Cancer
  • HPV Testing
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.
  • Cervical Cancer Mortality Population
  • 7.1 Population - Cervical Cancer Test

Global Cervical Cancer Screening Market is projected to reach US$ 7 Billion by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human Papillomavirus (HPV) Virus. Cervical cancer is the fourth most common cancer...

  • Cervical Cancer
  • Southeast Asia
  • Western Europe
  • World
  • Forecast
  • 14.2 Norway Cervical Cancer Mortality
  • 18.2 Japan Cervical Cancer Mortality

Global Cervical Market is expected to be close to US$ 7 Billion by 2020. North America controls almost 50 percent Cervical Cancer Market. United States and Japan together makes more than 50 percent market share. In Europe region, United Kingdom and France are other top two leading countries in this market place. Asia has highest share in cervical...

  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Sexually Transmitted Disease
  • Southeast Asia
  • Forecast

Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Cervical Cancer
  • France
  • United States
  • World
  • Forecast
  • Management of cervical cancer
  • Risk factors for cervical cancer

About cervical cancer Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified as squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma originates in the lining of the cervix, while adenocarcinoma arises...

  • Cancer
  • Cervical Cancer
  • World
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.
  • 6.2 Japan Cervical Cancer Mortality
  • 7.2 Korea Cervical Cancer Mortality

Cervical cancer test market in Asian region is growing and expected to cross over Billion dollars by 2020. Despite declining women population, Japan has highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervical cancer testing population followed by China. Growing women population, rising sum of structured...

  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Medical Device
  • Sexually Transmitted Disease
  • Forecast

Market Spotlight: Cervical Cancer CONTENTS ## OVERVIEW ## KEY TAKEAWAYS ## DISEASE BACKGROUND ## TREATMENT ## Surgery ## Radiotherapy ## Chemotherapy ## Targeted therapy ## EPIDEMIOLOGY ## MARKETED DRUGS ## Approvals by country ## PIPELINE DRUGS ## KEY UPCOMING EVENTS ## LICENSING AND ASS

  • Cancer
  • Cervical Cancer
  • United States
  • World
  • Market Description
  • 5.2 United States Cervical Cancer Mortality
  • 6.2 Canada Cervical Cancer Mortality

Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most preventable types of cancer. Pap smear and HPV DNA test are two most popular testing methods to diagnose...

  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Sexually Transmitted Disease
  • North America
  • Forecast

Cervical Cancer Phase ## Clinical Trials, 2016 ##.

  • Cervical Cancer
  • France
  • Germany
  • United States
  • Market Size
  • Europe Cervical Cancer Testing Market
  • 11.2 Switzerland Cervical Cancer Mortality

Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom...

  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Medical Device
  • Western Europe
  • Forecast

Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023 Report Introduction Cervical Cancer Disease Overview • Types of Cervical cancer • Staging of Cervical cancer • Pathophysiology • Etiology • Risk Factors Diag

  • Cancer
  • Cervical Cancer
  • United Kingdom
  • United States
  • Market Size

Cervical Cancer- Epidemiology Forecast to 2027 ##.

  • Cervical Cancer
  • France
  • Germany
  • Italy
  • Spain

Europe Cervical Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Cervical Cancer
  • Europe
  • France
  • Germany
  • Forecast

Asia Cervical Cancer Diagnostic Market, By Test Type, Countries & Forecast ##.

  • Cervical Cancer
  • Pathology
  • Asia
  • Forecast
  • Social Conditions

Europe Cervical Cancer Diagnostic Market & Forecast, By Test Type, Countries ##.

  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Europe
  • Social Conditions

Cervical Cancer - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Cancer
  • Cervical Cancer
  • Pathology
  • United States
  • Market Shares
  • CERVICAL CANCER
  • Burden of Cervical Cancer

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global HPV Vaccine Market by End-User (Male and Female), By Age-Group (Adolescent and Adults), By Region...

  • Cervical Cancer
  • Therapy
  • World
  • Market Size
  • GlaxoSmithKline plc

It is one of the most common cancer type diagnosed in women.

  • Cancer
  • Cervical Cancer
  • United States
  • Forecast
  • Market Size

Cervical Cancer Disease Coverage Forecast and Market Analysis to 2023 CONTENTS ## EPIDEMIOLOGY: CERVICAL CANCER ## Executive Summary ## Disease Background ## Sources and Methodology ## Forecast ## Epidemiologist Insight ## Strengths and Limitations ## APPENDIX ## A

  • Cancer
  • Cervical Cancer
  • European Union
  • Japan
  • United States
  • 6.1.2 GLAXOSMITHKLINE (GSK) - CERVICAL CANCER/HPV ADULT VACCINES SALES AND
  • 4.2.3 CERVICAL CANCER/ HPV - NUMBER OF VACCINES DOSES AND FORECAST

The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related...

  • Cervical Cancer
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.
  • FIGO staging of cervical cancer.
  • Incidence of cervical cancer by country.

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cervical Cancer in 22 Major Markets Cervical cancer (ICD-10 code C53, cervix uteri) is a type of cancer that occurs in the cells of the cervix. Cervical cancer is generally preceded by Cervical Intraepithelial Neoplasia (CIN). Nearly all cervical cancer...

  • Cancer
  • Cervical Cancer
  • Pathology

Cervical Cancer- Epidemiology Insights to 2023 Introduction Disease Overview Types of Cervical cancer Staging of Cervical cancer Pathophysiology Etiology Risk Factors Diagnosis Epidemiology and Patient Population United States Assumptions and Rat

  • Cervical Cancer
  • France
  • Germany
  • United Kingdom
  • United States
  • Survival rate for cervical cancer in select countries 2013
  • Cervical cancer mortality rate in APAC (per 100,000 women) 2015

About Gynecology Surgical Devices Gynecology surgical devices are in high demand for conditions including excessive uterine bleeding, ovarian cancer, cervical cancer, and others. Some conditions are treated without any complications, whereas, some of the procedures involve complications. Several advanced devices and technologies...

  • Cervical Cancer
  • World
  • Boston Scientific Corporation
  • CooperSurgical, Inc.
  • Hologic, Inc.

India Cervical Cancer Screening Market Outlook 2022 ##.

  • Cancer
  • Cervical Cancer
  • Health Services
  • India
  • Social Conditions

Cervical Cancer Phase ## Clinical Trials, 2016 ##.

  • Cervical Cancer
  • France
  • Germany
  • Italy
  • Market Size

Cervical Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Cervical Cancer
  • Pathology
  • United States
  • Market Size

Cervical Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Cervical Cancer
  • Pathology
  • Japan
  • Market Size

Cervical Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Cervical Cancer
  • Pathology
  • United Kingdom
  • Market Size